Title for MeetingAbstracts
Alphabetical listing of titles
Enhancement of HIV-1 production by various species of mycoplasmas from latently infected T and macrophage cell lines.
Enhancement of HIV-1 replication by perinatal CMV.
Enhancement of HIV-1 specific CTL responses during structured treatment interuptions (STI) following treated acute HIV-1-infection is associated with control of HIV-1 viremia.
ENHANCEMENT OF HIV-1 VIRAL PRODUCTION IN VITRO BY SUPERINFECTION.
Enhancement of HIV-1-Specific CTL Responses in the Peripheral Blood during STI is Largely Due to Redistribution of Pre-Existing Virus-Specific CD8+ T Cells from the Lymph Nodes.
Enhancement of HIV-Specific Immune Response during Structured Treatment Interruptions (STIs) in Chronic Infection Depends on Baseline Viral Load.
Enhancement of Host Resistance to Pneumococcal Pneumonia by the Combination of Interferon-Gamma and Ceftriaxone.
Enhancement of HTLV-I/II, HIV-I and HLA-DQ alpha PCR amplification efficiency using uracil-N-glycosylase.
Enhancement of human immunodeficiency virus (HIV) specific cytotoxic and helper T cell activities in asymptomatic HIV infected patients given recombinant gp160 vaccine.
Enhancement of human immunodeficiency virus type 1 infection by rantes is independent of the mechanism of virus-cell fusion.
Enhancement of human T-lymphopoiesis by growth hormone.
Enhancement of Immune Responses to HIV-1 by DNA Vaccination Using the Complement Protein, C3d.
Enhancement of Immune Responses with a DNA Vaccine Construct That Targets APCs.
Enhancement of immunogenicity of DNA vaccine by incorporating a 72-bp element from sv40 enhancer in the plasmid vector.
Enhancement of in vitro antibiotic susceptibility in Mycobacterium avium and Mycobacterium tuberculosis of poloxamers CRL-1072 and CRL-1605.
Enhancement of in vitro replication of cytomegalovirus (CMV) by IL-8.
Enhancement of lymphocyte-mediated, HIV specific antibody dependent cellular cytotoxicity by biologic response modifiers.
Enhancement of nasally administered HIV peptide immunogenicity using a polysaccharide bioadhesive.
Enhancement of Natural Killer Cell Number and Cytokine-driven Activation in HIV-1+ Patients Recieving Growth Hormone and HAART.
Enhancement of PCR specificity by uracil-N-glycosylase.
Enhancement of protective immunity against Coccidioides immitis by co-administration of an IL-12-expressing vector with Ag2 DNA vaccine.
Enhancement of Quality of life and well being of people living with AIDS.
Enhancement of retroviral transduction of stem cells by haemopoietic growth factors.
Enhancement of T-Cell growth, in HIV+ patients treated with ditiocarb (IMUTHIOL): evidence for monocyte involvement.
Enhancement of the anti-HIV effect of antisense oligonucleotides by delivery in pH-sensitive liposomes.
Enhancement of viral infectivity by HIV-1 nef.
Enhancement of virus infectivity: characterization of a signaling pathway utilized by the CC-chemokine RANTES to induce signals through interaction with glycosoaminoglycan receptors.
Enhancement/neutralization measured in the presence of complement predicts clinical progression in advanced stage HIV-1 disease.
Enhancements to the VIDAS probe Mycobacterium tuberculosis test.
Enhanchment of IDus through harm reduction program.